Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Genetic Technologies Limited v. Merial L.L.C.
Case Number:
15-1202
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
-
April 08, 2016
Fed. Circ. Rules That Mayo Dooms Gene Detection Patent
The Federal Circuit on Friday upheld a lower court's decision that many claims of a patent on a method of detecting genetic variations, which Genetic Technologies Ltd. asserted against Bristol-Myers Squibb Co. and a Sanofi-Aventis unit, are invalid because they claim only a natural law.
-
December 07, 2015
Fed. Circ. Urged To Revive 'Inventive' DNA Patent
Genetic Technologies Ltd. urged a Federal Circuit panel Monday to revive a DNA technology patent successfully challenged by Bristol-Myers Squibb Co. for claiming a process found in nature, arguing the patent includes an "inventive concept" for finding genetic variations in DNA.